Rolapitant For Prevention Of Chemotherapy-Induced Nausea And Vomiting In Patients Receiving Moderately Emetogenic Chemotherapy In The United States- Subgroup Analysis From A Randomized Phase Iii Trial
Abstract
Authors
LS Schwartzberg D Powers S Arora B Harrow ID Schnadig